Previously, we demonstrated that both increased promoter methylation and a rare germline variant (c.1-6531A>G) at the DAPK1 gene locus are associated with DAPK1 transcription and thereby contribute to CLL risk. Here, DAPK1 is linked to B-cell chronic lymphocytic leukemia.